| [86] |
Singh P, Germain MJ, Cohen L, et al. The elderly patient on dialysis: geriatric considerations[J]. Nephrol Dial Transplant, 2014, 29(5):990-996.
|
| [87] |
Quill TE, Holloway R. Time-limited trials near the end of life[J]. JAMA, 2011, 306(13):1483-1484.
|
| [88] |
Moist LM, Lok CE, Vachharajani TJ, et al. Optimal hemodialysis vascular access in the elderly patient[J]. Semin Dial, 2012, 25(6):640-648.
|
| [1] |
Tonelli M, Riella MC. World Kidney Day 2014: CKD and the aging population[J]. Am J Kidney Dis, 2014, 63(3):349-353.
|
| [2] |
Zhang L, Zhang P, Wang F, et al. Prevalence and factors associated with CKD: a population study from Beijing[J]. Am J Kidney Dis, 2008, 51(3): 373-384.
|
| [3] |
刘旭利，程庆砾，刘海波，等.社区高龄男性慢性肾脏病患者的营养和心理健康状况调查[J].中华全科医师杂志，2014，13（1）：32-36.
|
| [4] |
Zhang L, Wang F, Wang L, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey[J]. Lancet, 2012, 379(9818): 815-822.
|
| [5] |
Račić M, Petković N, Bogićević K, et al. Comprehensive geriatric assessment: comparison of elderly hemodialysis patients and primary care patients[J]. Ren Fail, 2015, 37(7):1126-1131.
|
| [6] |
Gołębiowski T, Augustyniak-Bartosik H, Weyde W, et al. Geriatric syndromes in patients with chronic kidney disease[J]. Postepy Hig Med Dosw, 2016, 70(10):581-589.
|
| [7] |
陈姝君，陈海平，李琳，等.血清肌酐评估肾功能在老年体检人群中的应用价值[J].中华健康管理学杂志，2012，6（2）：111-112.
|
| [8] |
陈姝君，陈海平，李琳.1008例老年健康体检者肾损害情况分析[J].中华老年医学杂志，2012，31（12）：1124-1126.
|
| [9] |
Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate[J]. Ann Intern Med, 2009, 150(9):604-612.
|
| [10] |
Flamant M, Haymann JP, Vidal-Petiot E, et al. GFR estimation using the Cockcroft-Gault, MDRD study, and CKD-EPI equations in the elderly[J]. Am J Kidney Dis, 2012, 60(5):847-849.
|
| [11] |
Kilbride HS, Stevens PE, Eaglestone G, et al. Accuracy of the MDRD (Modification of Diet in Renal Disease) study and CKD-EPI (CKD Epidemiology Collaboration) equations for estimation of GFR in the elderly[J]. Am J Kidney Dis, 2013, 61(1):57-66.
|
| [12] |
Inker LA, Schmid CH, Tighiouart H, et al. Estimating glomerular filtration rate from serum creatinine and cystatin C[J]. N Engl J Med, 2012, 367(1):20-29.
|
| [13] |
Schaeffner ES, Ebert N, Delanaye P, et al. Two novel equations to estimate kidney function in persons aged 70 years or older[J]. Ann Internal Med, 2012,157(7):471-481.
|
| [14] |
Fan L, Levey AS, Gudnason V, et al. Comparing GFR estimating equations using cystatin C and creatinine in elderly individuals[J]. J Am Soc Nephrol, 2015, 26(8):1982-1989.
|
| [15] |
Zhu Y, Ye X, Zhu B, et al. Comparisons between the 2012 new CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) equations and other four approved equations[J]. PLoS One, 2014, 9 (1):e84688.
|
| [16] |
陈荧，秦明照，郑洁.老年人慢性肾脏病分期的研究[J].中华老年医学杂志，2013，32（6）：602-604.
|
| [17] |
Kuznik A, Mardekian J, Tarasenko L. Evaluation of cardiovascular disease burden and therapeutic goal attainment in US adults with chronic kidney disease: an analysis of national health and nutritional examination survey data, 2001-2010[J]. BMC Nephrology, 2013, 14(1):132-143.
|
| [18] |
Winearls CG, Glassock RJ. Classification of chronic kidney disease in the elderly: pitfalls and errors[J]. Nephron Clin Pract, 2011, 119(suppl 1):c2-c4.
|
| [19] |
赵慧，李晓玫，王玉. 老年慢性肾脏病研究现状[J].中华老年医学杂志，2014，33（2）：214-218.
|
| [20] |
Bolignano D, Mattace-Raso F, Sijbrands EJ, et al. The aging kidney revisited: a systematic review[J]. Age Res Rev, 2014, 14:65-80.
|
| [21] |
Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease[J]. Kidney Int Supply, 2013, 3(1):1-150.
|
| [22] |
Musso CG, Reynaldi J, Martinez B, et al. Renal reserve in the oldest old[J]. Int Urolo Nephrol, 2011, 43(1):253-256.
|
| [23] |
Sharma A, Mucino MJ, Ronco C. Renal functional reserve and renal recovery after acute kidney injury[J]. Nephron Clin Pract, 2014, 127(1-4):94-100.
|
| [24] |
Coca SG, Cho KC, Chi-yuan Hsu CY. Acute kidney injury in the elderly: predisposition to chronic kidney disease and vice versa[J]. Nephron Clin Pract, 2011, 119(suppl 1):c19-c24.
|
| [25] |
Tonelli M, Muntner P, Lloyd A, et al. Impact of age on the association between CKD and the risk of future coronary events[J]. Am J Kidney Dis, 2014, 64(3):375-382.
|
| [26] |
Chronic Kidney Disease Prognosis Consortium. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis[J]. Lancet, 2010, 375(9731):2073-2081.
|
| [27] |
Thompson S, James M, Wiebe N, et al. Cause of death in patients with reduced kidney function[J]. J Am Soc Nephrol, 2015, 26(10):2504-2511.
|
| [89] |
Zheng Y, Cai GY, He LQ, et al. Efficacy and safety of niaoduqing particles for delaying moderate-to-severe renal dysfunction: a randomized, double-blind, placebo-controlled, multicenter clinical study[J]. Chin Med J (Engl), 2017, 130(20):2402-2409.
|
| [28] |
Oh SW, Kim S, Na KY, et al. Glomerular filtration rate and proteinuria: association with mortality and renal progression in a prospective cohort of a community-based elderly population[J]. PLoS One, 2014, 9(4):e94120.
|
| [29] |
Liu C, Chen H, Liu C, et al. Combined application of eGFR and albuminuria for the precise diagnosis of stage 2 and 3a CKD in the elderly[J]. J Nephrol, 2014, 27(3):289-297.
|
| [30] |
Chowdhury R, Peel NM, Krosch M, et al. Frailty and chronic kidney disease: a systematic review[J]. Arch Gerontol Geriatrics, 2017, 68: 135-142.
|
| [31] |
Hall RK, Haines C, Gorbatkin SM, et al. Incorporating geriatric assessment into a nephrology clinic: preliminary data from two models of care[J]. J Am Geriatri Soc, 2016, 64(10): 2154-2158.
|
| [32] |
Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype[J]. J Gerontol A Biol Sci Med Sci, 2001, 56(3):146-156.
|
| [33] |
陈旭娇，严静，王建业，等. 老年综合评估技术应用中国专家共识[J].中华老年医学杂志，2017，4（2）：1-6.
|
| [34] |
Corsonello A, Fusco S, Bustacchini S, et al. Special considerations for the treatment of chronic kidney disease in the elderly[J]. Exp Rev Clin Pharmacol, 2016, 9(5): 727-737.
|
| [35] |
Berger JR, Hedayati SS. Renal replacement therapy in the elderly population[J]. Clin J Am Soc Nephrol, 2012, 7(6):1039-1046.
|
| [36] |
Hallan SI, Matsushita K, Sang Y, et al. Age and the association of kidney measures with mortality and end-stage renal disease[J]. JAMA, 2012, 308(22):2349-2360.
|
| [37] |
Nitsch D, Grams M, Sang Y, et al. Associations of estimated glomerular filtration rate and albuminuria with mortality and renal failure by sex: a meta-analysis[J]. BMJ, 2013, 346:f324.
|
| [38] |
Zhu P, Zhou FD, Zhao MH. The renal histopathology spectrum of elderly patients with kidney diseases: a study of 430 patients in a single Chinese center[J]. Medicine (Baltimore), 2014, 93(28):e226.
|
| [39] |
Jin B, Zeng C, Ge Y, et al. The spectrum of biopsy-proven kidney diseases in elderly Chinese patients[J]. Nephrol Dial Transplant, 2014, 29(12):2251-2259.
|
| [40] |
Fischer MJ, O'Hare AM. Epidemiology of hypertension in the elderly with chronic kidney disease[J]. Adv Chro Kidney Dis, 2010, 17(4):329-340.
|
| [41] |
Sarafidis PA, Ruilope LM. Aggressive blood pressure reduction and renin-angiotensin system blockade in chronic kidney disease: time for re-evaluation[J]? Kidney Int, 2014, 85(3):536-546.
|
| [42] |
Lv J, Ehteshami P, Sarnak MJ, et al. Effects of intensive blood pressure lowering on the progression of chronic kidney disease: a systematic review and meta-analysis[J]. CMAJ, 2013, 185(11):949-957.
|
| [43] |
Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group. KDIGO clinical practice guideline for the management of blood pressure in chronic kidney disease[J]. Kidney Int Suppl, 2012, 2:337-414.
|
| [44] |
Inker LA, Okparavero A, Tighiouart H, et al. Midlife blood pressure and late-Life GFR and albuminuria: an elderly general population cohort[J]. Am J Kidney Dis, 2015, 66(2):240-248.
|
| [45] |
Kovesdy CP, Bleyer AJ, Molnar MZ, et al. Blood pressure and mortality in U.S. veterans with chronic kidney disease: a cohort study[J]. Ann Intern Med, 2013, 159(4):233-242.
|
| [46] |
Lohr JW, Golzy M, Carter RL, et al. Elevated systolic blood pressure is associated with increased incidence of chronic kidney disease but not mortality in elderly veterans[J]. J Am Soc Hypertens, 2015, 9(1):29-37.
|
| [47] |
Bulpitt CJ, Beckett NS, Peters R, et al. Blood pressure control in the hypertension in the very elderly trial (HYVET) [J]. J Hum Hypertens, 2012, 26(3):157-163.
|
| [48] |
中国老年医学学会高血压分会.高龄老年人血压管理中国专家共识[J].中国心血管杂志，2015，20（6）：401-409.
|
| [49] |
Liu YL, Prowle J, Licari E, et al. Changes in blood pressure before the development of nosocomial acute kidney injury[J]. Nephrol Dial Transplant, 2009, 24(2):504-511.
|
| [50] |
Zanasi A, Tincani E, Evandri V, et al. Meal-induced blood pressure variation and cardiovascular mortality in ambulatory hypertensive elderly patients: preliminary results[J]. J Hypertens, 2012, 30(11):2125-2132.
|
| [51] |
Sato N, Saijo Y, Sasagawa Y, et al. Visit-to-visit variability and seasonal variation in blood pressure: combination of antihypertensive therapy in the elderly, multicenter investigation (CAMUI) Trial subanalysis[J]. Clin Exp Hypertens, 2015, 37(5): 411-419.
|
| [52] |
Fried LF, Emanuele N, Zhang JH, et al. Combined angiotensin inhibition for the treatment of diabetic nephropathy[J]. N Engl J Med, 2013, 369(20):1892-1903.
|
| [53] |
Munshi MN, Pandya N, Umpierrez GE, et al. Contributions of basal and prandial hyperglycemia to total hyperglycemia in older and younger adults with type 2 diabetes mellitus[J]. J Am Geriatr Soc, 2013, 61(4):535-541.
|
| [54] |
中国老年学学会老年医学会老年内分泌代谢专业委员会/老年糖尿病诊疗措施专家共识编写组.老年糖尿病诊疗措施专家共识(2013年版) [J].中华内科杂志，2014，53（3）：243-251.
|
| [55] |
母义明，纪立农，宁光，等.二甲双胍临床应用专家共识（2016年）[J].中国糖尿病杂志，2016, 24（10）：871-883.
|
| [56] |
Lüders F, Bunzemeier H, Engelbertz C, et al. CKD and acute and long-term outcome of patients with peripheral artery disease and critical limb ischemia[J]. Clin J Am Soc Nephrol, 2016, 11(2):216-222.
|
| [57] |
Chen J, Mohler ER, Xie D, et al. Traditional and non-traditional risk factors for incident peripheral arterial disease among patients with chronic kidney disease[J]. Nephrol Dial Transplant, 2016, 31(7):1145-1151.
|
| [58] |
Aboyans V, Ricco JB, Bartelink MEL, et al. 2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries[J]. Eur Heart J, 2018, 39(9):763-816.
|
| [59] |
中华医学会外科学分会血管外科学组.深静脉血栓形成的诊断和治疗指南（第三版）[J].中华普通外科杂志，2017，32（9）：807-812.
|
| [60] |
Garneata L, Mircescu G. Effect of low-protein diet supplemented with keto acids on progression of chronic kidney disease[J]. J Ren Nutr, 2013, 23(3):210-213.
|
| [61] |
Garneata L, Stancu A, Dragomir D, et al. Ketoanalogue-supplemented vegetarian very low-protein diet and CKD progression[J]. J Am Soc Nephrol, 2016, 27(7):2164-2176.
|
| [62] |
刘旭利，程庆砾，刘胜，等.饮食蛋白的限制对高龄患者营养状况和慢性肾脏病进展的影响[J].中华临床医师杂志（电子版），2013，5（7）：1898-1902.
|
| [63] |
α酮酸制剂在肾内科应用专家协作组.慢性肾脏病蛋白营养治疗共识[J].中华肾脏病杂志，2005，21（7）：421-424.
|
| [64] |
Mirzaei H, Raynes R, Longo VD. The conserved role of protein restriction in aging and disease[J]. Curr Opin Clin Nutr Metab Care, 2016, 19(1):74-79.
|
| [65] |
Lorenzo-López L, Maseda A, de Labra C, et al. Nutritional determinants of frailty in older adults: a systematic review[J]. BMC Geriatr, 2017, 17(1):108.
|
| [66] |
Verlaan S, Ligthart-Melis GC, Wijers SLJ, et al. High prevalence of physical frailty among community-dwelling malnourished older adults-a systematic review and meta-analysis[J]. J Am Med Dir Assoc, 2017, 18(5):374-382.
|
| [67] |
Bellizzi V, Chiodini P, Cupisti A, et al. Very low-protein diet plus ketoacids in chronic kidney disease and risk of death during end-stage renal disease: a historical cohort controlled study[J]. Nephrol Dial Transplant, 2015, 30(1):71-77.
|
| [68] |
Ketteler M, Block GA, Evenepoel P, et al. Executive summary of the 2017 KDIGO chronic kidney disease-mineral and bone disorder (CKD-MBD) guideline update: what's changed and why it matters[J]. Kidney Int, 2017, 92(1):26-36.
|
| [69] |
Górriz JL, Molina P, Cerverón MJ, et al. Vascular calcification in patients with nondialysis CKD over 3 years[J]. Clin J Am Soc Nephrol, 2015, 10(4):654-666.
|
| [70] |
Jamal SA, Vandermeer B, Raggi P, et al. Effect of calcium-based versus non-calcium-based phosphate binders on mortality in patients with chronic kidney disease: an updated systematic review and meta-analysis[J]. Lancet, 2013, 382(9900):1268-1277.
|
| [71] |
Bover J, Ureña P, Brandenburg V, et al. Adynamic bone disease: from bone to vessels in chronic kidney disease[J]. Semin Nephrol, 2014, 34(6):626-640.
|
| [72] |
Wu VC, Huang TM, Lai CF, et al. Acute-on-chronic kidney injury at hospital discharge is associated with long-term dialysis and mortality[J]. Kidney Int, 2011, 80(11):1222-1230.
|
| [73] |
Xu X, Nie S, Liu Z, et al. Epidemiology and clinical correlates of AKI in Chinese hospitalized adults[J]. Clin J Am Soc Nephrol, 2015, 10(9):1510-1518.
|
| [74] |
Shankar-Hari M, Phillips GS, Levy ML, et al. Developing a new definition and assessing new clinical criteria for septic shock: for the third international consensus definitions for sepsis and septic shock (Sepsis-3) [J]. JAMA, 2016, 315(8):775-787.
|
| [75] |
Gordon AC, Mason AJ, Thirunavukkarasu N, et al. Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: the VANISH randomized clinical trial[J]. JAMA, 2016, 316(5):509-518.
|
| [76] |
Herzog CA, Asinger RW, Berger AK, et al. Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO) [J]. Kidney Int, 2011, 80(6):572-586.
|
| [77] |
Major RW, Cheung CK, Gray LJ, et al. Statins and cardiovascular primary prevention in CKD: a meta-analysis[J]. Clin J Am Soc Nephrol, 2015, 10(5): 732-739.
|
| [78] |
Jain N, Hedayati SS, Sarode R, et al. Antiplatelet therapy in the management of cardiovascular disease in patients with CKD: what is the evidence[J]? Clin J Am Soc Nephrol, 2013, 8(4):665-674.
|
| [79] |
Offurum A, Wagner LA, Gooden T. Adverse safety events in patients with Chronic Kidney Disease (CKD) [J]. Expert Opin Drug Saf, 2016, 15(12):1597-1607.
|
| [80] |
Pun PH. The interplay between CKD, sudden cardiac death, and ventricular arrhythmias[J]. Adv Chronic Kidney Dis, 2014, 21(6):480-488.
|
| [81] |
Whitman IR, Feldman HI, Deo R. CKD and sudden cardiac death: epidemiology, mechanisms, and therapeutic approaches[J]. J Am Soc Nephrol, 2012, 23(12):1929-1939.
|
| [82] |
Aucella F, Brunori G, Dalmartello M, et al. Assessment of the geriatric competence and perceived needs of Italian nephrologists: an internet survey[J]. J Nephrol, 2016, 29(3):385-390.
|
| [83] |
Berger JR, Jaikaransingh V, Hedayati SS. End-stage kidney disease in the elderly: approach to dialysis initiation, choosing modality, and predicting outcomes[J]. Adv Chronic Kidney Dis, 2016, 23(1):36-43.
|
| [84] |
Cheng X, Nayyar S, Wang M, et al. Mortality rates among prevalent hemodialysis patients in Beijing: a comparison with USRDS data[J]. Nephrol Dial Transplant, 2013, 28(3): 724-732.
|
| [85] |
Rosansky SJ, Schell J, Shega J, et al. Treatment decisions for older adults with advanced chronic kidney disease[J]. BMC Nephrol, 2017, 18(1):200.
|